[HTML][HTML] Vaccine value profile for Group B streptococcus

CL Trotter, M Alderson, Z Dangor, M Ip, K Le Doare… - Vaccine, 2023‏ - Elsevier
Group B streptococcus (GBS) is a major global cause of neonatal meningitis, sepsis and
pneumonia, with an estimated 91,000 infant deaths per year and an additional 46,000 …

Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness

SR Procter, BP Gonçalves, P Paul, J Chandna… - PLoS …, 2023‏ - journals.plos.org
Background Group B Streptococcus (GBS) can cause invasive disease (iGBS) in young
infants, typically presenting as sepsis or meningitis, and is also associated with stillbirth and …

Microbiological and clinical characteristics of invasive Group B Streptococcal blood stream infections in children and adults from Qatar

M Ali, MA Alamin, G A. Ali, K Alzubaidi, B Ali… - BMC Infectious …, 2022‏ - Springer
Abstract Introduction Group B Streptococci (GBS) colonize almost one third of human
gastrointestinal and genitourinary tracts, particularly in females. The aim of this study is to …

Maternal immunisation against neonatal invasive group B streptococcus could be cost effective in the Netherlands

BA Hahn - PharmacoEconomics & Outcomes News, 2021‏ - Springer
Maternal immunisation against neonatal invasive group B streptococcus (GBS) infection
using a potential trivalent GBS vaccine could be cost effective when implemented in addition …

[PDF][PDF] QUE PARA OBTENER EL TÍTULO DE

L ÍA - 2021‏ - ru.dgb.unam.mx
La sobrevida nacional en niños y adolescentes acorde con el Registro de Cáncer en Niños
y Adolescentes mexicanos (RCNA) es de 57%, en comparación con países con altos …